Germans Trias i Pujol Research Institute (IGTP)’s Post

💉New research shows that inclusive participation in clinical studies is hindered by translation costs. The U.S. Department of Health and Human Services requires consent information for prospective participants in clinical studies to be made available “in a language understandable to the subject”. A recent study found that one reason for low clinical study enrollment among patients from underrepresented racial and ethnic groups was the cost of consent document translation for clinical research investigators. Read more here: https://bit.ly/44y54js #research #science #equality #translation

A bibliometric analysis of the gender gap in the authorship of leading medical journals Monitoring gender representation is critical to achieve diversity and equity in academia. One way to evaluate gender representation in academia is to examine the authorship of research publications. This study sought to determine the gender of first and senior authors of articles in leading medical journals and assess trends in the gender gap over time. Methods We gather bibliometric data on original research articles (n = 10,558) published in 2010–2019 in five leading medical journals to audit publication and citation frequency by gender. We explored their association with scientific fields, geographical regions, journals, and collaboration scope. Results We show that there are fewer women as senior (24.8%) than leading authors (34.5%, p < 0.001). The proportion of women varied by country with 9.1% last authors from Austria, 0.9% from Japan, and 0.0% from South Korea. The gender gap decreased longitudinally and faster for the last (−24.0 articles/year, p < 0.001) than first authors (−14.5 articles/year, p = 0.024) with pronounced country-specific variability. We also demonstrate that usage of research keywords varied by gender, partly accounting for the difference in citation counts. Conclusions In summary, gender representation has increased, although with country-specific variability. The study frame can be easily applied to any journal and time period to monitor changes in gender representation in science. https://lnkd.in/e-ahVQTD

🌍 Critical Crossroads for US-China Scientific Collaboration 🌍 In 1991, approximately 25 babies per 100,000 births in the United States faced the daunting reality of spina bifida, a birth defect leading to paralysis and brain damage. Fifteen years later, the odds of this fate had diminished by nearly a third. The incredible breakthrough that could spare so many infants from this hardship was the revelation that folic acid supplements held the power to drastically reduce neural tube defects, including spina bifida and anencephalus. Described by Tom Frieden, former director of the US Centers for Disease Control and Prevention (CDC), as “one of the great successes of public health,” this achievement was born out of collaboration between the CDC in Atlanta and Peking University Health Science Center in Beijing, China. Today, this spirit of collaboration faces a perilous crossroads. The US-China Science and Technology Agreement, the foundation that facilitated the aforementioned birth defects study, stands on the brink of expiration on August 27. This agreement, a stalwart since its inception in 1979 following the normalization of US-China relations, typically renews every five years. Yet, as tensions escalate, the future of scientific cooperation between these two nations hangs in uncertainty. US legislators, represented by the select committee on China, are advocating for the agreement to lapse, fearing it could be weaponized by Beijing to further its military ambitions. Mike Gallagher, chair of the congressional committee on China, believes the agreement puts US intellectual property at risk. However, scientists assert that such a decision could impede progress on global challenges. Deborah Seligsohn, a political science professor at Villanova University and former science and technology counselor at the US embassy in Beijing, warns, “Failure to renew the agreement would have a highly negative impact on scientific cooperation of all kinds.” She adds that it could obstruct critical areas of collaboration, such as combatting climate change. China’s ambassador in Washington, Xie Feng, expresses Beijing’s desire for renewal. China has long reaped benefits from US funding and partnerships. Between 2015 and 2021, US government agencies allocated almost $30 million to Chinese initiatives, spanning disease surveillance, vaccine studies, and drone technology. President Xi Jinping’s reign has seen a doubling of annual spending on scientific research. A fervent proponent of “high quality growth” and technological self-reliance, particularly in strategic sectors like artificial intelligence, Xi’s administration continues to generously support research and development. In 2022, expenditures on basic research climbed by 13.5%, with total research and development spending exceeding 3 trillion yuan (£326.3 billion). #ScienceCollaboration #USChinaRelations #GlobalResearch #ScientificAdvancement #CollaborationOrCompetition #EvolvingPartnership

Medical Valley will welcome 🤗 Antoine Congost, project manager at IVADO, an AI consortium led by the University of Montreal, from 📅 June 25th to 27th, 2024. Besides the Erlangen/Nuremberg area Antoine will also stay in Munich. The visit is part of a collaborative project between the province of Québec, Canada, and Bavaria concerning the responsible use of #AI and data in the medical sector 🏥.   Our goals are: • meet and greet with the Medical Valley team and partners 🤝 • presenting the activities as well as the ecosystem within the field of responsible AI and data governance in healthcare of both the University of Montréal and IVADO 💾🔒 • exploring possible collaborations 👋   If you´d like to join a one-on-one with Antoine or learn more about the initiative reach Caroline Hofmann via 📧 [email protected]   Université de Montréal | Consortium Santé Numérique - Université de Montréal | Marco Wendel | Isabella Seiler   #MedicalValley #KI #Digitalisierung

An afternoon of learning thanks to this workshop National Heart, Lung, and Blood Institute National Institutes of Health (NIH): Intramural Research Program (IRP). ▶️ The purpose of the workshop is to improve the use of big-data for population studies by promoting an understanding of current scientific research. The workshop will create a platform for researchers to discuss the importance of data standards and harmonization for reproducibility in research. This will allow for the sharing of ideas and experiences in integrating different data sources and types, as well as leveraging established data tools and techniques. The goal is to encourage collaboration and networking among researchers from various fields in order to share best practices and insights on data integration and analysis. The workshop also aims to inspire innovative approaches to epidemiological research by integrating diverse data sources and utilizing advanced data analysis tools and techniques. ⬇️⬇️⬇️⬇️⬇️⬇️ https://lnkd.in/grK7HnYB

Is the scientific publication, as we know it, dead?   That was last year’s central theme for the challenge at the Danish Diabetes and Endocrine Academy's postdoc summit. We challenged the participants to not only discuss the problems but also suggest potential solutions. It is incredible what strong ideas can develop in such a relatively short time.   From the summit, we summarized the postdoc summit challenge output and made a “roadshow” presentation and a poster. We then travelled around Denmark giving talks and poster presentations at different workshops, conferences and meetings. Lot’s of great input from the scientific community.   Now, we are ready to share the #preprint of all the work and ideas of how to re-think scientific publications and the whole system around publications and its role in science. From a perspective of early career researchers in #diabetes, #metabolism and classical #endocrinology.   https://lnkd.in/dCg4jtRe   A key point from the discussion was that the scientific publication is not going to die. But it needs to change. Change to follow the rapid development of science and society.   Big thanks to the DDEA for playing along with our crazy ideas, to the writing group (Morten Dall, Katharina Herzog, Benjamin Lebiecka-Johansen, Philip Ruppert, Jessica Preston, Antonia Sophie Hufnagel, Christina Yfanti, Pearlyn Toh), to all those who travelled the country to present and to all the attendees at the 2023 postdoc summit.   Note, there is still time to sign up to this years postdoc summit: https://lnkd.in/dvtsae5u DEADLINE is June 23 (very soon)! I feel a vast amount of FOMO after seeing the excellent program. Can't wait to learn what comes out of the challenge this year.

【#CubicZine】AI Connecting Patient Voices❤️ Voice•Link : Walking Alongside the Rare Disease Community ✨ “#SCA is a group of chronic genetic diseases that lead to the gradual death of cerebellar cells. We hope to seize the opportunity while patients still have language abilities and use artificial intelligence technology to assist patients and caregivers in communication.” InnoPort recently interviewed Professor Chan Ho Yin (Edwin Chan) from the Faculty of Science at The Chinese University of Hong Kong (CUHK). Professor Chan, who started his career as a scientist, has now become a social innovation leader. He is spearheading the "Voice•Link" project, which brings together the new generation of students from different universities to drive social innovation. We are pleased to announce that the "Voice•Link" project has recently received funding from the CUHK Knowledge Transfer Project Fund (#KPF). This support allows academic knowledge to be transformed into tangible community actions and applications. ▍ Learn more about KPF👉 ORKTS - Social Innovation Team ▍ Watch the video and Click LIKE 👉 https://lnkd.in/e4eW9dJK ▍ Subscribe Cubic Zine for Free 👉https://bit.ly/3Dn2BOV 🌟 Key points of the interview ▍ About Prof. Chan👉 https://lnkd.in/e7STHGiz ▍ “AI Phonograph” for Rare Disease Patients👉https://lnkd.in/eabu9nSK ▍ Mutual learning - Students reignite the professor's original intention ▍ No boundaries - Providing comprehensive assistance to the rare disease community ▍ Beyond the topic - Looking at the future of rare diseases from multiple perspectives: Learning from rare disease policies in mainland China === #CUHK #Innovation #Entreprenuership #KnowledgeTransfer #ORKTS #CUHKInnoPort #Technology #RareDisease #AI #Funding

Labour unveils new life sciences sector plan in a bid to increase growth - Digital Health #LabourUnveilsNewLifeSciencesSectorPlan #IncreasingGrowthInLifeSciencesSector The Labour party has revealed a new plan aimed at boosting growth in the life sciences sector. The plan includes several key initiatives that focus on research, development, and innovation. #InvestingInResearchAndDevelopment Labour plans to invest in research and development (R&D) to drive innovation in the life sciences sector. This includes increasing funding for R&D and creating incentives for businesses to invest in R&D activities. #PromotingCollaborationBetweenIndustryAndAcademia The party aims to foster collaboration between industry and academia to accelerate the translation of research into practical applications. Labour plans to establish partnerships between universities, research institutions, ai.mediformatica.com #health #labour #innovation #lifesciences #clinicaltrials #research #britain #investment #researchanddevelopment #socialcare #technology #dhsc #digitalhealth #healthit #healthtech #healthcaretechnology @MediFormatica (https://buff.ly/3UsacnE)

Research wastage, for example redundant studies or inadequate reporting, is an unfortunate but not uncommon issues in the medical R&I landscape. How could Evidence-Based Research (EBR) help minimise wastage? EBR involves using prior research to inform new studies in a systematic and transparent manner. COST Action EVBRES spent the last 4 years promoting more valuable and less redundant research, working with researchers, funders, and the wider community. Klara Brunnhuber, Vice-Chair of the network talks to us about EBR, the achievements of EVBRES, and how this network will continue it's activities as 'The Evidence-Based Research Network'. Learn more 🔗 https://lnkd.in/eKJ7Rnva #COSTactions #ScienceWithoutBorders #ResearchWaste